Advertisement

Index by author

January 01, 1994; Volume 45,Issue 1

A

  1. Aharony, D

    1. Isolation and pharmacological characterization of a hamster urinary bladder neurokinin A receptor cDNA.
      D Aharony, J Little, C Thomas, S Powell, D Berry and A Graham
      Molecular Pharmacology January 1994, 45 (1) 9-19;

  2. al-Tikriti, M S

    1. Active and inactive enantiomers of 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane: comparison using homogenate binding and single photon emission computed tomographic imaging.
      B E Scanley, R M Baldwin, M Laruelle, M S al-Tikriti, Y Zea-Ponce, S Zoghbi, S S Giddings, D S Charney, P B Hoffer and S Wang
      Molecular Pharmacology January 1994, 45 (1) 136-141;

B

  1. Baldwin, R M

    1. Active and inactive enantiomers of 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane: comparison using homogenate binding and single photon emission computed tomographic imaging.
      B E Scanley, R M Baldwin, M Laruelle, M S al-Tikriti, Y Zea-Ponce, S Zoghbi, S S Giddings, D S Charney, P B Hoffer and S Wang
      Molecular Pharmacology January 1994, 45 (1) 136-141;

  2. Bean, B P

    1. Inhibition of P-type and N-type calcium channels by dopamine receptor antagonists.
      D W Sah and B P Bean
      Molecular Pharmacology January 1994, 45 (1) 84-92;

  3. Berry, D

    1. Isolation and pharmacological characterization of a hamster urinary bladder neurokinin A receptor cDNA.
      D Aharony, J Little, C Thomas, S Powell, D Berry and A Graham
      Molecular Pharmacology January 1994, 45 (1) 9-19;

  4. Borkowski, J A

    1. Differential pharmacology of cloned human and mouse B2 bradykinin receptors.
      J F Hess, J A Borkowski, T Macneil, G Y Stonesifer, J Fraher, C D Strader and R W Ransom
      Molecular Pharmacology January 1994, 45 (1) 1-8;

  5. Bylund, D B

    1. The cloning and expression of an OK cell cDNA encoding a 5-hydroxytryptamine1B receptor.
      D R Cerutis, N A Hass, L J Iversen and D B Bylund
      Molecular Pharmacology January 1994, 45 (1) 20-28;

C

  1. Cadieux, A

    1. Conformational and biological studies of neuropeptide Y analogs containing structural alterations.
      A Fournier, D Gagnon, R Quirion, A Cadieux, Y Dumont, L H Pheng and S St-Pierre
      Molecular Pharmacology January 1994, 45 (1) 93-101;

  2. Cannon, S D

    1. A G protein-activated K+ current in bovine adrenal chromaffin cells: possible regulatory role in exocytosis.
      S D Cannon, S P Wilson and K B Walsh
      Molecular Pharmacology January 1994, 45 (1) 109-116;

  3. Cederbaum, A I

    1. Generation of reactive oxygen intermediates by human liver microsomes in the presence of NADPH or NADH.
      J Rashba-Step and A I Cederbaum
      Molecular Pharmacology January 1994, 45 (1) 150-157;

  4. Cerutis, D R

    1. The cloning and expression of an OK cell cDNA encoding a 5-hydroxytryptamine1B receptor.
      D R Cerutis, N A Hass, L J Iversen and D B Bylund
      Molecular Pharmacology January 1994, 45 (1) 20-28;

  5. Charney, D S

    1. Active and inactive enantiomers of 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane: comparison using homogenate binding and single photon emission computed tomographic imaging.
      B E Scanley, R M Baldwin, M Laruelle, M S al-Tikriti, Y Zea-Ponce, S Zoghbi, S S Giddings, D S Charney, P B Hoffer and S Wang
      Molecular Pharmacology January 1994, 45 (1) 136-141;

  6. Chio, C L

    1. Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors.
      C L Chio, M E Lajiness and R M Huff
      Molecular Pharmacology January 1994, 45 (1) 51-60;

D

  1. Domalewski, M D

    1. Continuous spectrofluorometric analysis of formyl peptide receptor ternary complex interactions.
      R G Posner, S P Fay, M D Domalewski and L A Sklar
      Molecular Pharmacology January 1994, 45 (1) 65-73;

  2. Donevan, S D

    1. Hydrophobic interactions of n-alkyl diamines with the N-methyl-D-aspartate receptor: voltage-dependent and -independent blocking sites.
      S Subramaniam, S D Donevan and M A Rogawski
      Molecular Pharmacology January 1994, 45 (1) 117-124;

  3. Dumont, Y

    1. Conformational and biological studies of neuropeptide Y analogs containing structural alterations.
      A Fournier, D Gagnon, R Quirion, A Cadieux, Y Dumont, L H Pheng and S St-Pierre
      Molecular Pharmacology January 1994, 45 (1) 93-101;

F

  1. Fay, S P

    1. Continuous spectrofluorometric analysis of formyl peptide receptor ternary complex interactions.
      R G Posner, S P Fay, M D Domalewski and L A Sklar
      Molecular Pharmacology January 1994, 45 (1) 65-73;

  2. Fournel-Gigleux, S

    1. A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids.
      M Pritchard, S Fournel-Gigleux, G Siest, P Mackenzie and J Magdalou
      Molecular Pharmacology January 1994, 45 (1) 42-50;

  3. Fournier, A

    1. Conformational and biological studies of neuropeptide Y analogs containing structural alterations.
      A Fournier, D Gagnon, R Quirion, A Cadieux, Y Dumont, L H Pheng and S St-Pierre
      Molecular Pharmacology January 1994, 45 (1) 93-101;

  4. Fracella, F

    1. Heat shock response and cytotoxicity in C6 rat glioma cells: structure-activity relationship of different alcohols.
      U Neuhaus-Steinmetz, C Xu, F Fracella, B Oberheitmann, C Richter-Landsberg and L Rensing
      Molecular Pharmacology January 1994, 45 (1) 36-41;

  5. Fraher, J

    1. Differential pharmacology of cloned human and mouse B2 bradykinin receptors.
      J F Hess, J A Borkowski, T Macneil, G Y Stonesifer, J Fraher, C D Strader and R W Ransom
      Molecular Pharmacology January 1994, 45 (1) 1-8;

G

  1. Gagnon, D

    1. Conformational and biological studies of neuropeptide Y analogs containing structural alterations.
      A Fournier, D Gagnon, R Quirion, A Cadieux, Y Dumont, L H Pheng and S St-Pierre
      Molecular Pharmacology January 1994, 45 (1) 93-101;

  2. Giddings, S S

    1. Active and inactive enantiomers of 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane: comparison using homogenate binding and single photon emission computed tomographic imaging.
      B E Scanley, R M Baldwin, M Laruelle, M S al-Tikriti, Y Zea-Ponce, S Zoghbi, S S Giddings, D S Charney, P B Hoffer and S Wang
      Molecular Pharmacology January 1994, 45 (1) 136-141;

  3. Ginzburg, I

    1. Neurites induced by staurosporine in PC12 cells are resistant to colchicine and express high levels of tau proteins.
      D Rasouly, E Rahamim, I Ringel, I Ginzburg, C Muarakata, Y Matsuda and P Lazarovici
      Molecular Pharmacology January 1994, 45 (1) 29-35;

  4. Graham, A

    1. Isolation and pharmacological characterization of a hamster urinary bladder neurokinin A receptor cDNA.
      D Aharony, J Little, C Thomas, S Powell, D Berry and A Graham
      Molecular Pharmacology January 1994, 45 (1) 9-19;

H

  1. Hass, N A

    1. The cloning and expression of an OK cell cDNA encoding a 5-hydroxytryptamine1B receptor.
      D R Cerutis, N A Hass, L J Iversen and D B Bylund
      Molecular Pharmacology January 1994, 45 (1) 20-28;

  2. Heinemann, S F

    1. Partial agonist properties of cytisine on neuronal nicotinic receptors containing the beta 2 subunit.
      R L Papke and S F Heinemann
      Molecular Pharmacology January 1994, 45 (1) 142-149;

  3. Hess, J F

    1. Differential pharmacology of cloned human and mouse B2 bradykinin receptors.
      J F Hess, J A Borkowski, T Macneil, G Y Stonesifer, J Fraher, C D Strader and R W Ransom
      Molecular Pharmacology January 1994, 45 (1) 1-8;

  4. Himel, C M

    1. Conformers of acetylcholinesterase: a mechanism of allosteric control.
      J L Taylor, R T Mayer and C M Himel
      Molecular Pharmacology January 1994, 45 (1) 74-83;

  5. Hoffer, P B

    1. Active and inactive enantiomers of 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane: comparison using homogenate binding and single photon emission computed tomographic imaging.
      B E Scanley, R M Baldwin, M Laruelle, M S al-Tikriti, Y Zea-Ponce, S Zoghbi, S S Giddings, D S Charney, P B Hoffer and S Wang
      Molecular Pharmacology January 1994, 45 (1) 136-141;

  6. Hoffman, B J

    1. Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding.
      Z B Pristupa, J M Wilson, B J Hoffman, S J Kish and H B Niznik
      Molecular Pharmacology January 1994, 45 (1) 125-135;

  7. Hue, L

    1. Flunarizine and cinnarizine inhibit mitochondrial complexes I and II: possible implication for parkinsonism.
      K Veitch and L Hue
      Molecular Pharmacology January 1994, 45 (1) 158-163;

  8. Huff, R M

    1. Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors.
      C L Chio, M E Lajiness and R M Huff
      Molecular Pharmacology January 1994, 45 (1) 51-60;

I

  1. Iversen, L J

    1. The cloning and expression of an OK cell cDNA encoding a 5-hydroxytryptamine1B receptor.
      D R Cerutis, N A Hass, L J Iversen and D B Bylund
      Molecular Pharmacology January 1994, 45 (1) 20-28;

K

  1. Kish, S J

    1. Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding.
      Z B Pristupa, J M Wilson, B J Hoffman, S J Kish and H B Niznik
      Molecular Pharmacology January 1994, 45 (1) 125-135;

L

  1. Lajiness, M E

    1. Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors.
      C L Chio, M E Lajiness and R M Huff
      Molecular Pharmacology January 1994, 45 (1) 51-60;

  2. Laruelle, M

    1. Active and inactive enantiomers of 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane: comparison using homogenate binding and single photon emission computed tomographic imaging.
      B E Scanley, R M Baldwin, M Laruelle, M S al-Tikriti, Y Zea-Ponce, S Zoghbi, S S Giddings, D S Charney, P B Hoffer and S Wang
      Molecular Pharmacology January 1994, 45 (1) 136-141;

  3. Lazarovici, P

    1. Neurites induced by staurosporine in PC12 cells are resistant to colchicine and express high levels of tau proteins.
      D Rasouly, E Rahamim, I Ringel, I Ginzburg, C Muarakata, Y Matsuda and P Lazarovici
      Molecular Pharmacology January 1994, 45 (1) 29-35;

  4. Little, J

    1. Isolation and pharmacological characterization of a hamster urinary bladder neurokinin A receptor cDNA.
      D Aharony, J Little, C Thomas, S Powell, D Berry and A Graham
      Molecular Pharmacology January 1994, 45 (1) 9-19;

M

  1. Mackenzie, P

    1. A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids.
      M Pritchard, S Fournel-Gigleux, G Siest, P Mackenzie and J Magdalou
      Molecular Pharmacology January 1994, 45 (1) 42-50;

  2. Macneil, T

    1. Differential pharmacology of cloned human and mouse B2 bradykinin receptors.
      J F Hess, J A Borkowski, T Macneil, G Y Stonesifer, J Fraher, C D Strader and R W Ransom
      Molecular Pharmacology January 1994, 45 (1) 1-8;

  3. Magdalou, J

    1. A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids.
      M Pritchard, S Fournel-Gigleux, G Siest, P Mackenzie and J Magdalou
      Molecular Pharmacology January 1994, 45 (1) 42-50;

  4. Matsuda, Y

    1. Neurites induced by staurosporine in PC12 cells are resistant to colchicine and express high levels of tau proteins.
      D Rasouly, E Rahamim, I Ringel, I Ginzburg, C Muarakata, Y Matsuda and P Lazarovici
      Molecular Pharmacology January 1994, 45 (1) 29-35;

  5. Mayer, R T

    1. Conformers of acetylcholinesterase: a mechanism of allosteric control.
      J L Taylor, R T Mayer and C M Himel
      Molecular Pharmacology January 1994, 45 (1) 74-83;

  6. Miller, K W

    1. Ethanol stabilizes the open channel state of the Torpedo nicotinic acetylcholine receptor.
      G Wu, P H Tonner and K W Miller
      Molecular Pharmacology January 1994, 45 (1) 102-108;

  7. Muarakata, C

    1. Neurites induced by staurosporine in PC12 cells are resistant to colchicine and express high levels of tau proteins.
      D Rasouly, E Rahamim, I Ringel, I Ginzburg, C Muarakata, Y Matsuda and P Lazarovici
      Molecular Pharmacology January 1994, 45 (1) 29-35;

N

  1. Neuhaus-Steinmetz, U

    1. Heat shock response and cytotoxicity in C6 rat glioma cells: structure-activity relationship of different alcohols.
      U Neuhaus-Steinmetz, C Xu, F Fracella, B Oberheitmann, C Richter-Landsberg and L Rensing
      Molecular Pharmacology January 1994, 45 (1) 36-41;

  2. Niznik, H B

    1. Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding.
      Z B Pristupa, J M Wilson, B J Hoffman, S J Kish and H B Niznik
      Molecular Pharmacology January 1994, 45 (1) 125-135;

O

  1. Oberheitmann, B

    1. Heat shock response and cytotoxicity in C6 rat glioma cells: structure-activity relationship of different alcohols.
      U Neuhaus-Steinmetz, C Xu, F Fracella, B Oberheitmann, C Richter-Landsberg and L Rensing
      Molecular Pharmacology January 1994, 45 (1) 36-41;

P

  1. Papke, R L

    1. Partial agonist properties of cytisine on neuronal nicotinic receptors containing the beta 2 subunit.
      R L Papke and S F Heinemann
      Molecular Pharmacology January 1994, 45 (1) 142-149;

  2. Pheng, L H

    1. Conformational and biological studies of neuropeptide Y analogs containing structural alterations.
      A Fournier, D Gagnon, R Quirion, A Cadieux, Y Dumont, L H Pheng and S St-Pierre
      Molecular Pharmacology January 1994, 45 (1) 93-101;

  3. Pittel, Z

    1. Intramolecular interactions in muscarinic acetylcholine receptors studied with chimeric m2/m5 receptors.
      Z Pittel and J Wess
      Molecular Pharmacology January 1994, 45 (1) 61-64;

  4. Posner, R G

    1. Continuous spectrofluorometric analysis of formyl peptide receptor ternary complex interactions.
      R G Posner, S P Fay, M D Domalewski and L A Sklar
      Molecular Pharmacology January 1994, 45 (1) 65-73;

  5. Powell, S

    1. Isolation and pharmacological characterization of a hamster urinary bladder neurokinin A receptor cDNA.
      D Aharony, J Little, C Thomas, S Powell, D Berry and A Graham
      Molecular Pharmacology January 1994, 45 (1) 9-19;

  6. Pristupa, Z B

    1. Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding.
      Z B Pristupa, J M Wilson, B J Hoffman, S J Kish and H B Niznik
      Molecular Pharmacology January 1994, 45 (1) 125-135;

  7. Pritchard, M

    1. A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids.
      M Pritchard, S Fournel-Gigleux, G Siest, P Mackenzie and J Magdalou
      Molecular Pharmacology January 1994, 45 (1) 42-50;

Q

  1. Quirion, R

    1. Conformational and biological studies of neuropeptide Y analogs containing structural alterations.
      A Fournier, D Gagnon, R Quirion, A Cadieux, Y Dumont, L H Pheng and S St-Pierre
      Molecular Pharmacology January 1994, 45 (1) 93-101;

R

  1. Rahamim, E

    1. Neurites induced by staurosporine in PC12 cells are resistant to colchicine and express high levels of tau proteins.
      D Rasouly, E Rahamim, I Ringel, I Ginzburg, C Muarakata, Y Matsuda and P Lazarovici
      Molecular Pharmacology January 1994, 45 (1) 29-35;

  2. Ransom, R W

    1. Differential pharmacology of cloned human and mouse B2 bradykinin receptors.
      J F Hess, J A Borkowski, T Macneil, G Y Stonesifer, J Fraher, C D Strader and R W Ransom
      Molecular Pharmacology January 1994, 45 (1) 1-8;

  3. Rashba-Step, J

    1. Generation of reactive oxygen intermediates by human liver microsomes in the presence of NADPH or NADH.
      J Rashba-Step and A I Cederbaum
      Molecular Pharmacology January 1994, 45 (1) 150-157;

  4. Rasouly, D

    1. Neurites induced by staurosporine in PC12 cells are resistant to colchicine and express high levels of tau proteins.
      D Rasouly, E Rahamim, I Ringel, I Ginzburg, C Muarakata, Y Matsuda and P Lazarovici
      Molecular Pharmacology January 1994, 45 (1) 29-35;

  5. Rensing, L

    1. Heat shock response and cytotoxicity in C6 rat glioma cells: structure-activity relationship of different alcohols.
      U Neuhaus-Steinmetz, C Xu, F Fracella, B Oberheitmann, C Richter-Landsberg and L Rensing
      Molecular Pharmacology January 1994, 45 (1) 36-41;

  6. Richter-Landsberg, C

    1. Heat shock response and cytotoxicity in C6 rat glioma cells: structure-activity relationship of different alcohols.
      U Neuhaus-Steinmetz, C Xu, F Fracella, B Oberheitmann, C Richter-Landsberg and L Rensing
      Molecular Pharmacology January 1994, 45 (1) 36-41;

  7. Ringel, I

    1. Neurites induced by staurosporine in PC12 cells are resistant to colchicine and express high levels of tau proteins.
      D Rasouly, E Rahamim, I Ringel, I Ginzburg, C Muarakata, Y Matsuda and P Lazarovici
      Molecular Pharmacology January 1994, 45 (1) 29-35;

  8. Rogawski, M A

    1. Hydrophobic interactions of n-alkyl diamines with the N-methyl-D-aspartate receptor: voltage-dependent and -independent blocking sites.
      S Subramaniam, S D Donevan and M A Rogawski
      Molecular Pharmacology January 1994, 45 (1) 117-124;

S

  1. Sah, D W

    1. Inhibition of P-type and N-type calcium channels by dopamine receptor antagonists.
      D W Sah and B P Bean
      Molecular Pharmacology January 1994, 45 (1) 84-92;

  2. Scanley, B E

    1. Active and inactive enantiomers of 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane: comparison using homogenate binding and single photon emission computed tomographic imaging.
      B E Scanley, R M Baldwin, M Laruelle, M S al-Tikriti, Y Zea-Ponce, S Zoghbi, S S Giddings, D S Charney, P B Hoffer and S Wang
      Molecular Pharmacology January 1994, 45 (1) 136-141;

  3. Siest, G

    1. A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids.
      M Pritchard, S Fournel-Gigleux, G Siest, P Mackenzie and J Magdalou
      Molecular Pharmacology January 1994, 45 (1) 42-50;

  4. Sklar, L A

    1. Continuous spectrofluorometric analysis of formyl peptide receptor ternary complex interactions.
      R G Posner, S P Fay, M D Domalewski and L A Sklar
      Molecular Pharmacology January 1994, 45 (1) 65-73;

  5. St-Pierre, S

    1. Conformational and biological studies of neuropeptide Y analogs containing structural alterations.
      A Fournier, D Gagnon, R Quirion, A Cadieux, Y Dumont, L H Pheng and S St-Pierre
      Molecular Pharmacology January 1994, 45 (1) 93-101;

  6. Stonesifer, G Y

    1. Differential pharmacology of cloned human and mouse B2 bradykinin receptors.
      J F Hess, J A Borkowski, T Macneil, G Y Stonesifer, J Fraher, C D Strader and R W Ransom
      Molecular Pharmacology January 1994, 45 (1) 1-8;

  7. Strader, C D

    1. Differential pharmacology of cloned human and mouse B2 bradykinin receptors.
      J F Hess, J A Borkowski, T Macneil, G Y Stonesifer, J Fraher, C D Strader and R W Ransom
      Molecular Pharmacology January 1994, 45 (1) 1-8;

  8. Subramaniam, S

    1. Hydrophobic interactions of n-alkyl diamines with the N-methyl-D-aspartate receptor: voltage-dependent and -independent blocking sites.
      S Subramaniam, S D Donevan and M A Rogawski
      Molecular Pharmacology January 1994, 45 (1) 117-124;

T

  1. Taylor, J L

    1. Conformers of acetylcholinesterase: a mechanism of allosteric control.
      J L Taylor, R T Mayer and C M Himel
      Molecular Pharmacology January 1994, 45 (1) 74-83;

  2. Thomas, C

    1. Isolation and pharmacological characterization of a hamster urinary bladder neurokinin A receptor cDNA.
      D Aharony, J Little, C Thomas, S Powell, D Berry and A Graham
      Molecular Pharmacology January 1994, 45 (1) 9-19;

  3. Tonner, P H

    1. Ethanol stabilizes the open channel state of the Torpedo nicotinic acetylcholine receptor.
      G Wu, P H Tonner and K W Miller
      Molecular Pharmacology January 1994, 45 (1) 102-108;

V

  1. Veitch, K

    1. Flunarizine and cinnarizine inhibit mitochondrial complexes I and II: possible implication for parkinsonism.
      K Veitch and L Hue
      Molecular Pharmacology January 1994, 45 (1) 158-163;

W

  1. Walsh, K B

    1. A G protein-activated K+ current in bovine adrenal chromaffin cells: possible regulatory role in exocytosis.
      S D Cannon, S P Wilson and K B Walsh
      Molecular Pharmacology January 1994, 45 (1) 109-116;

  2. Wang, S

    1. Active and inactive enantiomers of 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane: comparison using homogenate binding and single photon emission computed tomographic imaging.
      B E Scanley, R M Baldwin, M Laruelle, M S al-Tikriti, Y Zea-Ponce, S Zoghbi, S S Giddings, D S Charney, P B Hoffer and S Wang
      Molecular Pharmacology January 1994, 45 (1) 136-141;

  3. Wess, J

    1. Intramolecular interactions in muscarinic acetylcholine receptors studied with chimeric m2/m5 receptors.
      Z Pittel and J Wess
      Molecular Pharmacology January 1994, 45 (1) 61-64;

  4. Wilson, J M

    1. Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding.
      Z B Pristupa, J M Wilson, B J Hoffman, S J Kish and H B Niznik
      Molecular Pharmacology January 1994, 45 (1) 125-135;

  5. Wilson, S P

    1. A G protein-activated K+ current in bovine adrenal chromaffin cells: possible regulatory role in exocytosis.
      S D Cannon, S P Wilson and K B Walsh
      Molecular Pharmacology January 1994, 45 (1) 109-116;

  6. Wu, G

    1. Ethanol stabilizes the open channel state of the Torpedo nicotinic acetylcholine receptor.
      G Wu, P H Tonner and K W Miller
      Molecular Pharmacology January 1994, 45 (1) 102-108;

X

  1. Xu, C

    1. Heat shock response and cytotoxicity in C6 rat glioma cells: structure-activity relationship of different alcohols.
      U Neuhaus-Steinmetz, C Xu, F Fracella, B Oberheitmann, C Richter-Landsberg and L Rensing
      Molecular Pharmacology January 1994, 45 (1) 36-41;

Z

  1. Zea-Ponce, Y

    1. Active and inactive enantiomers of 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane: comparison using homogenate binding and single photon emission computed tomographic imaging.
      B E Scanley, R M Baldwin, M Laruelle, M S al-Tikriti, Y Zea-Ponce, S Zoghbi, S S Giddings, D S Charney, P B Hoffer and S Wang
      Molecular Pharmacology January 1994, 45 (1) 136-141;

  2. Zoghbi, S

    1. Active and inactive enantiomers of 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane: comparison using homogenate binding and single photon emission computed tomographic imaging.
      B E Scanley, R M Baldwin, M Laruelle, M S al-Tikriti, Y Zea-Ponce, S Zoghbi, S S Giddings, D S Charney, P B Hoffer and S Wang
      Molecular Pharmacology January 1994, 45 (1) 136-141;
Back to top

In this issue

Advertisement